Skip to content

Clinical trials

Phase 2 COVID-19 trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: COVID-19 Phase: Phase 2 Country / region: United Kingdom Clear all

27 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20181
202018
20216
20221
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed14
Terminated9
Withdrawn3
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
University College, London3
4D pharma plc1
Apeiron Biologics1
Cancer Research UK1
Chiesi Farmaceutici S.p.A.1
Gates Medical Research Institute1
GlaxoSmithKline1
Hoffmann-La Roche1
Imperial College Healthcare NHS Trust1
Karyopharm Therapeutics Inc1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
COVID-1927
Coronavirus Infections7
Pneumonia2
Acute Lung Injury1
Anemia, Sickle Cell1
Diabetes Mellitus1
Hypoxia1
Leukemia1
Lung Diseases, Interstitial1
Lymphoma1

Trials

Showing 1 to 25 of 27. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.